Stress granule assembly is a trigger for tumor necrosis factor alpha production in SH-SY5Y neuroblastoma cells
Tumor necrosis factor alpha (TNF-α) is a key pro-inflammatory cytokine that orchestrates innate immune responses to infections and other cellular stressors. Chronic inflammation causes persistent TNF-α overproduction, which promotes apoptosis and necroptosis. Excessive production of TNF-α contributes to neurodegeneration in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and multiple sclerosis. Although anti-TNF-α antibodies are effective in treating autoimmune diseases such as rheumatoid arthritis, they cannot penetrate the brain and reduce TNF-α levels in neuronal cells. Here, we investigate the role of stress granule formation in regulating TNF-α production in human SH-SY5Y neuroblastoma cells. Stress granules are dynamic membraneless ribonucleoprotein complexes that assemble in response to various stress stimuli. They contain RNAs, RNA-binding proteins, and ribosomal components. In particular, the RNA-binding proteins TIA-1, TIAR, and FXR1, which negatively regulate TNF mRNA translation, are incorporated into stress granules under stress. Using immunocytochemistry, we show that FXR1 is progressively recruited to stress granules during sodium arsenite-induced stress in SH-SY5Y cells. Sequestration of FXR1 into stress granules disrupts its interaction with TNF mRNA, resulting in increased TNF-α production. Furthermore, pharmacological inhibition of stress granule assembly by the integrated stress response inhibitor (ISRIB) prevents stress-induced excessive TNF-α production in SH-SY5Y cells. Thus, our findings indicate that stress granule assembly triggers TNF-α production. Given that some known stress granule inhibitors can cross the blood–brain barrier, we propose that they may be promising agents for reducing the excessive neurotoxic production of TNF-α during neuroinflammation, provided that our findings are confirmed in other cell cultures and in vivo .
Authors
- Vladimir A. Mitkevich (ORCID: https://orcid.org/0000-0002-1517-1983)
- Alexander А. Makarov (ORCID: https://orcid.org/0000-0001-6220-6969)
- Tatyana A. Belashova (ORCID: https://orcid.org/0000-0001-9433-6987)
- Evgeniy I. Sysoev (ORCID: https://orcid.org/0000-0003-1444-9784)
- Alexey P. Galkin (ORCID: https://orcid.org/0000-0002-7362-8857)
- Anna A. Valina (ORCID: https://orcid.org/0009-0004-8951-2295)
Institutions
- Engelhardt Institute of Molecular Biology (RU)
- Russian Academy of Sciences (RU)
- St Petersburg University (RU)
- Vavilov Institute of General Genetics (RU)
Publication Details
- Journal
- Frontiers in Molecular Neuroscience
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3389/fnmol.2026.1959410
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Saint Petersburg State University
- Russian Science Foundation